I like the way the stock has performed sense Eastern Cap made their purchase. The following is a sample of their recent acquisitions, they seem to know and like undervalued Biotech.
Company/Relationship Reported Shares Ownership Cyclacel Pharmaceuticals, Inc. Beneficial Owner (10% or more) NasdaqGM:CYCC (historical quotes, profile, other insiders) 9-Mar-15 5,607,143 Direct Cytokinetics, Incorporated
Beneficial Owner (10% or more) NasdaqCM:CYTK (historical quotes, profile, other insiders) 25-Feb-14 2,883,845 Direct iBio, Inc. Beneficial Owner (10% or more) NYSE MKT:IBIO (historical quotes, profile, other insiders) 26-Apr-13 14,460,000 Direct
TAPIMMUNE INC Beneficial Owner (10% or more) Other OTC:TPIV (historical quotes, other insiders) 9-Mar-15 5,000,000 Direct
Insider & restricted shareholder transactions reported over the last two years Date Shares Stock Transaction 9-Mar-15 5,607,143 CYCC Statement of Ownership 9-Mar-15 5,000,000 TPIV Statement of Ownership 25-Feb-14 500,000 CYTK Purchase at $8 per share. (Cost of $4,000,000) 26-Apr-13 4,460,000 IBIO Purchase